RMCM
Reynders McVeigh Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,850
| Closed | -$667K | – | 226 |
|
|
2019
Q2 | $667K | Sell |
2,850
-12,771
| -82% | -$2.99M | 0.07% | 125 |
|
|
2019
Q1 | $3.69M | Sell |
15,621
-1,588
| -9% | -$375K | 0.41% | 48 |
|
|
2018
Q4 | $5.18M | Sell |
17,209
-1,275
| -7% | -$384K | 0.69% | 35 |
|
|
2018
Q3 | $6.53M | Buy |
18,484
+860
| +5% | +$304K | 0.77% | 34 |
|
|
2018
Q2 | $5.12M | Buy |
17,624
+3,077
| +21% | +$893K | 0.65% | 38 |
|
|
2018
Q1 | $3.98M | Buy |
14,547
+3,797
| +35% | +$1.04M | 0.5% | 40 |
|
|
2017
Q4 | $3.43M | Buy |
10,750
+6,075
| +130% | +$1.94M | 0.45% | 46 |
|
|
2017
Q3 | $1.46M | Buy |
4,675
+3,646
| +354% | +$1.14M | 0.19% | 82 |
|
|
2017
Q2 | $279K | Buy |
1,029
+20
| +2% | +$5.42K | 0.04% | 184 |
|
|
2017
Q1 | $276K | Sell |
1,009
-66
| -6% | -$18.1K | 0.04% | 187 |
|
|
2016
Q4 | $305K | Sell |
1,075
-13
| -1% | -$3.69K | 0.04% | 183 |
|
|
2016
Q3 | $341K | Sell |
1,088
-186
| -15% | -$58.3K | 0.05% | 168 |
|
|
2016
Q2 | $308K | Buy |
1,274
+107
| +9% | +$25.9K | 0.04% | 175 |
|
|
2016
Q1 | $304K | Buy |
1,167
+67
| +6% | +$17.5K | 0.05% | 182 |
|
|
2015
Q4 | $337K | Hold |
1,100
| – | – | 0.06% | 154 |
|
|
2015
Q3 | $321K | Buy |
1,100
+425
| +63% | +$124K | 0.06% | 163 |
|
|
2015
Q2 | $273K | Buy |
+675
| New | +$273K | 0.04% | 174 |
|